examination of the effects of liraglutide on diabetic nephropathy
Liraglutide (Lira), a glucagon-like peptide-1 receptor agonist, can be administered to diabetic patients with renal failure without dose reduction, but experience with the use of Lira in these patients is limited. This study was designed to examine the effects of 6-month Lira administration on gluco...
Saved in:
Main Authors: | Akihiro Ryuge (Author), Kusama Minoru (Author), Kouchi Yu (Author), Ozeki Takaya (Author), Yazawa Masahiko (Author), Yamaguchi Makoto (Author), Ohyama Yukako (Author), Haji Yoichiro (Author), Imaizumi Takahiro (Author), Tomino Tatsuhito (Author), Shimizu Hideaki (Author), Nakashima Eitaro (Author), Fujita Yoshiro (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Nephrology,
2012-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RELATIONSHIP BETWEEN SALT INTAKE AND GNRI IN ELDERLY DIALYSIS PATIENTS
by: Takaya Ozeki, et al.
Published: (2012) -
Liraglutide-induced injection site reaction
by: Nada Fouda Neel, et al.
Published: (2019) -
Liraglutide in the management of type 2 diabetes
by: Estela Wajcberg, et al.
Published: (2010) -
Liraglutide abrogates nephrotoxic effects of chemotherapies
by: Cong Xu, et al.
Published: (2023) -
Clinical Impact of Liraglutide as a Treatment of Obesity
by: Alruwaili H, et al.
Published: (2021)